• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Opioids show no benefit for treating chronic musculoskeletal pain versus non-opioid treatments

byDaniel Fisher
March 12, 2018
in Chronic Disease, Emergency, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this pragmatic, randomized controlled trial, opioids did not result in better pain management or function compared to non-opioid treatments for patients with chronic pain.

2. Opioids resulted in more medication-related symptoms than non-opioid treatments.

Evidence Rating Level: 2 (Excellent)

Study Rundown: Chronic pain remains one of the most difficult conditions to treat in medicine, and with rising rates of opioid abuse, there has been much scrutiny as to their usefulness in treating chronic pain. Despite this, there has yet to be a randomized trial comparing opioid to non-opioid treatments that measures long term pain severity, function, and quality of life outcomes. In this pragmatic, randomized controlled trial of Minnesota VA patients with knee or back osteoarthritis, non-opioid therapies decreased pain intensity more than opioids to a moderate though significant degree and neither pain-related functioning nor health-related quality of life differed between groups after 1 year of treatment. In addition, there were more medication-related symptoms in the opioid group compared to the non-opioid group, though the rate of adverse events were similar between groups. Subgroup analysis by location of pain was similar to analysis of the whole.

Though the pragmatic nature of the trial has certain weaknesses, namely increased uncontrolled variables such as non-pharmacological pain control and lack of blinding, the strength of analyzing patients under real-world conditions greatly strengthens the conclusions of the study. The major weakness lies in the generalizability of the study results, as VA patients are not always representative of other populations, especially in terms of gender. Still, the high retention rate of subjects and strong design greatly support the assertion that opioid treatments may not be the most suitable for chronic musculoskeletal pain.

Click to read the study, published in JAMA

Relevant Reading: The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop

RELATED REPORTS

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

Steep decline in post-operative opioid prescriptions for common pediatric surgeries

Maternal substance use may increase risk of childhood Attention Deficit Hyperactivity Disorder

In-Depth [randomized controlled trial]: A total of 240 patients (98% follow-up rate) from 62 Minnesota VA primary care clinicians were randomized to receive opioid or non-opioid treatment for chronic pain due to back or knee osteoarthritis for 12 months in the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial. Patients were excluded if they were already on long-term opioid therapy, had contraindications to either treatment including substance use disorder, and had conditions that could interfere with a 12-month assessment, such as life expectancy less than 12 months. Patients were encouraged to seek out other non-pharmacological pain treatments, and patients with depression or PTSD were not excluded. Using the Brief Pain Inventory scores, patients who received non-opioid treatment displayed better BPI pain severity ratings than those who received opioids (difference 0.5; CI95 0.0 to 1.0). The two groups were comparable for pain-related function (difference 0.1; -0.5 to 0.7), physical health-related quality of life (difference -1.3; CI95 -3.8 to 1.3), and mental health-related quality of life (difference 0.7; CI95 -2.4 to 3.8). Opioids were associated with a higher rate of adverse events (difference 0.9; CI95 0.3 to 1.5) but no significant differences in adverse events or misuse measures (p > 0.5). Post-hoc tests for interaction of pain location and treatment were non-significant (p > 0.5) and adjusting for baseline smoking status as a sensitivity analysis did not change the associations.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: arthritischronic painopioids
Previous Post

Single PSA screening increases prostate cancer detection but does not change mortality

Next Post

Increased inhaled glucocorticoids do not prevent asthma exacerbations in children: The STICS trial

RelatedReports

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia
StudyGraphics

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

May 4, 2022
Gastroenterology

Steep decline in post-operative opioid prescriptions for common pediatric surgeries

April 5, 2022
Social networks play key roles in parental vaccination decisions
Chronic Disease

Maternal substance use may increase risk of childhood Attention Deficit Hyperactivity Disorder

March 15, 2022
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Knee extensor muscle weakness may be a risk factor for osteoarthritis

February 2, 2022
Next Post
Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Increased inhaled glucocorticoids do not prevent asthma exacerbations in children: The STICS trial

Development of a risk index for colorectal cancer screening

iPad app that allows patients to order tests doubles colon cancer screening rates in study

AAP supports mindfulness of children’s media consumption

Stricter state firearm laws associated with lower rates of firearm suicide and homicide

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.